Steroid Diabetes in Patients With Kidney Disease

Recruiting now

Conditions studied: Nephrotic Syndrome

In brief

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Key facts

Study ID

NCT06161701

Run by

Zhejiang Provincial People's Hospital

People needed

300

Starts

2024-01-10

Expected to finish

2027-02-28

Last updated by the study team

2024-04-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus；
• Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone；

You may not qualify if…

• Patients with diabetes；
• Those who are unable to communicate through language；
• Uremic patients；
• Unable to perform blood glucose monitoring and follow-up as required；
• Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone；
• Participated in other clinical studies。

Where it is running

• Zhejiang provincial people's hospital — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.